|
|
Effect of baicalin capsules on acute mountain sickness in healthy young males at acute high altitude exposure |
DUAN Wei1, SUN Shuhong1, HUI Zengqian1, GAO Zhao1, HU Jianku1, JIN Feng2, CHEN Hong3 |
1.Shanxi Provincial Corps Hospital, Chinese People’s Armed Police Forces, Xi’an 710054, China; 2. Hygiene Division of Logistics Department of Tibet Autonomous Regional Corps, Chinese People’s Armed Police Forces, Lhasa 850005, China; 3. Department of Pharmacognosy and Pharmaceutics, Logistics Univercity of Chinese People’s Armed Police Forces, Tianjin 300162, China |
|
|
Abstract Objective To investigate the effect of baicalin capsules for acute mountain sickness(AMS) prevention with rapid airlift ascent to high altitude. Methods A randomized controlled trial was conducted on 80 healthy young men with baicalin capsules (0.5 g bid, n=32), rhodiola capsules (0.76 g bid, n=24), or placebo (n=24), for 2 days prior to airlift ascent (397 m) and for the first 3 days at high altitude (3658 m). AMS, oxygen saturation (SpO2), heart rate (HR), systolic blood pressure(SBP), diastolic blood pressure(DBP), pulmonary artery systolic pressure (PASP) and mean pulmonary arterial pressure (MPAP) were assessed both at 397 m and 3658 m. Results After high-altitude exposure, significantly fewer participants in the baicalin capsules group(n=8, 25.0%) and rhodiola capsules group(n=7, 29.2%) developed acute mountain sickness compared with participants receiving placebo (n=14, 58.3%) (P<0.05) . HR, SBP, DBP, PASP and MPAP increased with altitude exposure (P<0.05), and SpO2 decreased with altitude exposure (P<0.05). AMS, HR, SBP and DBP with baicalin capsules was lower than those with placebo (P<0.05); AMS, PASP, MPAP with rhodiola capsules were lower than those with placebo (P<0.05) and SpO2 was higher than that with placebo (P<0.05). Conclusions Baicalin capsules for AMS prevention also reduce HR, SBP and DBP with rapid airlift ascent to high altitude and rhodiola capsules for AMS prevention also reduce PASP, MPAP, increase SpO2 with rapid airlift ascent to high altitude.
|
Received: 28 July 2014
|
|
|
|
|
[8] |
张喜平, 程琪辉, 沈培红. 黄芩苷类注射剂安全性与急性毒性实验研究[J]. 医学研究杂志, 2007, 16(7): 23-25.
|
[9] |
髙 钊, 曹 波, 张 力, 等. 黄芩苷对肺动脉高压大鼠模型的治疗作用及可能的机制[J]. 心脏杂志, 2013, 25(4): 56-58.
|
[1] |
Niermeyer S, Zamudio S, Moore LG. High altitude- an exploration of human adaptation[M]. New York: marcel Dekker, 2001: 43-100.
|
[10] |
Zhang Lin, Pu Zhichen, Wang Junsong, et al. Baicalin inhibits hypoxia-induced pulmonary artery smooth muscle cell proliferation via the AKT/HIF-1α/p27-associated pathway [J]. Int J Mol Sci, 2014, 15(5): 8153-8168.
|
[2] |
Bartsch P, Gibbs J S. Effect of altitude on the heart and the lungs [J]. Circulation, 2007, 116: 2191-2202.
|
[11] |
RenY, Fu Z, Shen W, et al. Incidence of high altitude illnesses among unacclimatized persons who acutely ascended to Tibet [J]. High Alt Med Biol, 2010, 11(1): 39-44.
|
[3] |
Hackett P H, Roach R C. High-altitude illness [J]. N Engl J Med, 2001, 345(2): 107-114.
|
[12] |
Dean A G, Yip R, Hoffimann R E. High incidence of mild acute mountain sickness in conference attendees at 10, 000 foot altitude [J]. J Wildeness Med, 1990, 1(2):86-92.
|
[13] |
León-Velarde F, Villafuerte F C, Richalet J P. Chronic mountain sickness and the heart [J]. Prog Cardiovasc Dis, 2010, 52: 540-549.
|
[14] |
刘 阳, 张继航, 黄 岚, 等. 高原暴露人群动脉血压变化与急性高原病的相关性分析[J]. 解放军医学杂志, 2014, 39(3): 226-230.
|
[15] |
王淑琴, 柯国萍, 黄云峰, 等. 长驻高原地区中青年官兵高血压患病率及危险因素分析[J]. 武警医学, 2014, 25(3): 235 -236.
|
[16] |
Hainsworth R, Drinkhill M J, Rivera-Chira M. The autonomic nervous system at high altitude[J]. Clin Auton Res, 2007, 17(1): 13-19.
|
[17] |
傅守廷, 赵乃才. 黄芩甙对儿茶酚胺的拮抗作用[J]. 中国医科大学学报, 1987, 16(6): 176-178.
|
[18] |
付守廷, 付 宇. 黄芩苷的耐缺氧作用[J]. 沈阳药科大学学报, 2001, 18(3): 207-209.
|
[19] |
Bhagi S, Srivastava S, Singh S B. High-altitude pulmonary edema [J]. J Occup Health, 2014, 56(4): 235-243.
|
[4] |
Kupper T, Gieseler U, Angelini C, et al. Emergency field management of acute mountain sickness, high altitude pulmonary edema, and high altitude cerebral edema[M]. Bern, Switzerland:UIAA Medical Commision Press, 2008: 2-3.
|
[5] |
Hackett P H, Rennie D, Levine H D. The incidence, importance, and prophylaxis of acute mountain sickness [J]. Lancet, 1976, 2: 1149-1155.
|
[20] |
Lee S Y, Li M H, Shi LS, et al. Rhodiola crenulata extract alleviates hypoxic pulmonary edema in Rats [J]. Evid Based Complement Alternat Med, 2013, 69(3): 9-12.
|
[6] |
Wu T Y. Mountain rescue: the highest earthquake in Yushu[J].High Alt Med Biol, 2011, 12(1): 93-95.
|
[7] |
文 敏, 李 雪, 付守廷. 黄芩苷药理作用研究新进展[J]. 沈阳药科大学学报, 2008, 25(2): 67-71.
|
[8] |
张喜平, 程琪辉, 沈培红. 黄芩苷类注射剂安全性与急性毒性实验研究[J]. 医学研究杂志, 2007, 16(7): 23-25.
|
[9] |
髙 钊, 曹 波, 张 力, 等. 黄芩苷对肺动脉高压大鼠模型的治疗作用及可能的机制[J]. 心脏杂志, 2013, 25(4): 56-58.
|
[10] |
Zhang Lin, Pu Zhichen, Wang Junsong, et al. Baicalin inhibits hypoxia-induced pulmonary artery smooth muscle cell proliferation via the AKT/HIF-1α/p27-associated pathway [J]. Int J Mol Sci, 2014, 15(5): 8153-8168.
|
[11] |
RenY, Fu Z, Shen W, et al. Incidence of high altitude illnesses among unacclimatized persons who acutely ascended to Tibet [J]. High Alt Med Biol, 2010, 11(1): 39-44.
|
[12] |
Dean A G, Yip R, Hoffimann R E. High incidence of mild acute mountain sickness in conference attendees at 10, 000 foot altitude [J]. J Wildeness Med, 1990, 1(2):86-92.
|
[13] |
León-Velarde F, Villafuerte F C, Richalet J P. Chronic mountain sickness and the heart [J]. Prog Cardiovasc Dis, 2010, 52: 540-549.
|
[14] |
刘 阳, 张继航, 黄 岚, 等. 高原暴露人群动脉血压变化与急性高原病的相关性分析[J]. 解放军医学杂志, 2014, 39(3): 226-230.
|
[15] |
王淑琴, 柯国萍, 黄云峰, 等. 长驻高原地区中青年官兵高血压患病率及危险因素分析[J]. 武警医学, 2014, 25(3): 235 -236.
|
[16] |
Hainsworth R, Drinkhill M J, Rivera-Chira M. The autonomic nervous system at high altitude[J]. Clin Auton Res, 2007, 17(1): 13-19.
|
[17] |
傅守廷, 赵乃才. 黄芩甙对儿茶酚胺的拮抗作用[J]. 中国医科大学学报, 1987, 16(6): 176-178.
|
[18] |
付守廷, 付 宇. 黄芩苷的耐缺氧作用[J]. 沈阳药科大学学报, 2001, 18(3): 207-209.
|
[19] |
Bhagi S, Srivastava S, Singh S B. High-altitude pulmonary edema [J]. J Occup Health, 2014, 56(4): 235-243.
|
[20] |
Lee S Y, Li M H, Shi LS, et al. Rhodiola crenulata extract alleviates hypoxic pulmonary edema in Rats [J]. Evid Based Complement Alternat Med, 2013, 69(3): 9-12.
|
[1] |
. [J]. Med. J. Chin. Peop. Armed Poli. Forc., 2019, 30(2): 159-161. |
|
|
|
|